Research Article
Antimicrobial Resistance and Associated Risk Factors for Clostridium difficile in Patients Attending Tertiary Care Settings
Table 2
Phenotypic antimicrobial susceptibility patterns among C. difficile strains (n = 108) using the disc diffusion assay.
| | Antibiotic | Code | Concentration (μg) | S n (%) | I n (%) | R n (%) |
| | Ampicillin | AMP | 10 | 12 (11.1) | 6 (5.6) | 90 (83.3) | | Cefixime | CFM | 10 | 30 (27.7) | 27 (9.2) | 51 (47.2) | | Cefepime | CEF | 30 | 38 (35.1) | 10 (10.4) | 60 (55.5) | | Amoxycillin + clav. acid | AMC | 30 | 10 (13.8) | 22 (19.4) | 81 (70) | | Nalidixic acid | NA | 30 | 27 (25) | 15 (13.8) | 66 (61.1) | | Ciprofloxacin | CIP | 5 | 35 (13.8) | 22 (20.3) | 51 (47.2) | | Levofloxacin | LEV | 5 | 72 (66.6) | 10 (9.4) | 26 (24) | | SXT | SXT | 25 | 32 (30) | 16 (13) | 60 (55.5) | | Chloramphenicol | CMP | 30 | 45 (41.6) | 6 (5.2) | 57 (52.7) | | Imipenem | IPM | 10 | 96 (88.8) | 8 (7.4) | 4 (3.7) | | Vancomycin | VAN | 10 | 101 (93.5) | — | 7 (6.4) | | Metronidazole | MTZ | 15 | 53 (21.2) | 14 (6.4) | 41 (38) |
|
|
S = sensitive, I = intermediate, R = resistant.
|
